Amgen Inc. (
) will begin trading ex-dividend on February 11, 2013. A cash
dividend payment of $0.47 per share is scheduled to be paid on
March 07, 2013. Shareholders who purchased AMGN stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 30.56% increase over the prior quarter.
The previous trading day's last sale of AMGN was $86.59,
representing a -4.65% decrease from the 52 week high of $90.81 and
a 32.46% increase over the 52 week low of $65.37.
AMGN is a part of the Health Care sector, which includes
companies such as Gilead Sciences, Inc. (
) and Biogen Idec Inc. (
). AMGN's current earnings per share, an indicator of a company's
profitability, is $5.51. Zacks Investment Research reports AMGN's
forecasted earnings growth in 2013 as 5.77%, compared to an
industry average of 11.2%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to AMGN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AMGN as a top-10 holding:
- iShares NASDAQ Biotechnology Index Fund (
- PowerShares Dynamic Biotech &Genome (
- PowerShares Dynamic Pharmaceuticals (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
The top-performing ETF of this group is XLV with an increase of
9.69% over the last 100 days. IBB has the highest percent weighting
of AMGN at 8.1%.